Skip to main content
Year archive

BioInvent International — 2019 filings

All 45 regulatory filings released by BioInvent International (BINV) in 2019, sourced directly from the official regulator.

45 Filings
2019 Period
2019 filings (45)
Filing Released Lang
BioInvent announces selection of second target and extension of the research collaboration and license agreement with Pfizer Inc.
Regulatory Filings
2019-12-23 English
BioInvent meddelar val av andra målstrukturen samt förlängning av forskningssamarbetet och licensavtalet med Pfizer Inc.
Regulatory Filings
2019-12-23 Swedish
BioInvent Has Entered into a Clinical Trial Collaboration and Supply Agreement to Evaluate BI-1206 in Combination with KEYTRUDA[®] in Advanced Solid Tumors
Regulatory Filings
2019-12-18 English
BioInvent har ingått ett samarbets- och leveransavtal för en klinisk prövning för utvärdering av BI-1206 i kombination med KEYTRUDA[®] i avancerade solida tumörer
Regulatory Filings
2019-12-18 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q3 2019
2019-10-24 Swedish
Earnings Release 2019
Earnings Release 9M 2019
2019-10-24 English
BioInvent signs manufacturing agreement with Cancer Research UK expected to generate approximately SEK 30 million (~$3 million)
Regulatory Filings
2019-10-23 English
BioInvent tecknar produktionsavtal med Cancer Research UK som förväntas generera cirka 30 miljoner kronor (~3 miljoner USD)
Regulatory Filings
2019-10-23 Swedish
Earnings Release 2019
Earnings Release H1 2019
2019-08-22 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report H1 2019
2019-08-22 English
USPTO intends to grant BioInvent patent relating to BI-1206
Regulatory Filings
2019-08-15 English
USPTO avser bevilja BioInvent patent relaterat till BI-1206
Regulatory Filings
2019-08-15 Swedish
Inbjudan till presentation av BioInvent’s delårsrapport för andra kvartalet, 2019 den 22 augusti 2019
Report Publication Announcement
2019-08-14 Swedish
Invitation to presentation of BioInvent’s Interim Report Q2-2019 on August 22, 2019
Report Publication Announcement
2019-08-14 English
BioInvent meddelar val av första målstrukturen som identifierats med BioInvents teknologiplattform F.I.R.S.TTM under samarbetet med Pfizer Inc.
Regulatory Filings
2019-07-31 Swedish
BioInvent announces selection of first target discovered by BioInvent’s proprietary F.I.R.S.TTM technology platform under collaboration with Pfizer Inc.
Regulatory Filings
2019-07-31 English
Change in the number of shares and votes in BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2019-06-28 English
Ändring av antalet aktier och röster i BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2019-06-28 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-22 Swedish
Interim / Quarterly Report 2019
Interim / Quarterly Report Q1 2019
2019-05-22 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-05-03 English
Major Shareholding Notification 2019
Major Shareholding Notification
2019-05-02 Swedish
Change in the number of shares and votes in BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2019-04-30 English
Ändring av antalet aktier och röster i BioInvent International AB
Share Issue/Capital Change
2019-04-30 Swedish
BioInvent erhåller milstolpsbetalning på 0,75 miljoner euro inom ramen för samarbetet med Mitsubishi Tanabe Pharma
Capital/Financing Update
2019-04-26 Swedish
BioInvent receives €0.75 million milestone under Mitsubishi Tanabe Pharma partnership
Regulatory Filings
2019-04-26 English
Beslut på BioInvents årsstämma 2019
AGM Information
2019-04-25 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-03 Swedish
Annual Report 2018
Annual Report FY 2018
2019-04-03 English
Ändring av antalet aktier och röster i BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2019-03-29 Swedish
Change in the number of shares and votes in BioInvent International AB
Declaration of Voting Results & Voting Rights Announcements
2019-03-29 English
BioInvent offentliggör prospekt avseende företrädesemission och riktad emission
Capital/Financing Update
2019-03-21 Swedish
BioInvent publishes prospectus relating to the rights issue and directed issue
Capital/Financing Update
2019-03-21 English
Resolutions at the Extraordinary General Meeting in BioInvent 2019
AGM Information
2019-03-20 English
Beslut på BioInvents extra bolagsstämma 2019
Share Issue/Capital Change
2019-03-20 Swedish
Notice to Annual General Meeting in BioInvent International AB
AGM Information
2019-03-19 English
Kallelse till årsstämma i BioInvent International AB
AGM Information
2019-03-19 Swedish
BioInvent expands US patent protection for its F.I.R.S.T.™ platform
Legal Proceedings Report
2019-03-13 English
BioInvent utvidgar patentskyddet i USA för bolagets plattform F.I.R.S.T.™
Regulatory Filings
2019-03-13 Swedish
Audit Report / Information 2018
Audit Report / Information FY 2018
2019-02-25 Swedish
Interim / Quarterly Report 2018
Interim / Quarterly Report FY 2018
2019-02-25 English
Notice of Extraordinary General Meeting in BioInvent International AB
AGM Information
2019-02-25 English
Kallelse till extra bolagsstämma i BioInvent International AB
AGM Information
2019-02-25 Swedish
BioInvent erhåller särläkemedelsstatus från FDA för BI-1206 för mantelcellslymfom
Regulatory Filings
2019-01-30 Swedish
BioInvent receives FDA orphan designation for BI-1206 for mantle cell lymphoma
Regulatory Filings
2019-01-30 English